Previous studies indicated that gangliogliomas with BRAF V600E mutations have an increased risk for progression and recurrence [35], especially for tumors located in the brainstem, where BRAF V600E mutant gangliogliomas show a shorter progression free survival compared to wild type gangliogliomas [36,37]. The gene discussed is BRAF; the disease is ganglioglioma.